Hyperion Defi HYPD
NASDAQ HYPD
$3.18 +0.04 (+1.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Hyperion Defi (HYPD) Liabilities and Shareholders Equity (2016 - 2026)

Hyperion Defi (HYPD) posted quarterly Liabilities and Shareholders Equity of $70.1 million for Q1 2026, up 1070.9% year-over-year from $6.0 million in Q1 2025, and up 35.36% quarter-over-quarter from $51.8 million in Q4 2025.

Hyperion Defi (HYPD) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

Hyperion Defi (HYPD) has reported Liabilities and Shareholders Equity for 11 consecutive years, with $70.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 1070.9% year-over-year to $70.1 million; the TTM figure through Mar 2026 stood at $260.3 million (up 405.96% YoY), while the FY2025 annual figure was $51.8 million, up 1311.33% from the prior year.
  • Liabilities and Shareholders Equity improved to $70.1 million in Q1 2026 per HYPD's latest filing, from $51.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $82.8 million in Q3 2025 and bottomed at $3.7 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $35.2 million across 5 years, with a median of $31.0 million in 2022.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity slumped 87.26% — and 2025, when it jumped 1311.33%.
  • Hyperion Defi's Liabilities and Shareholders Equity stood at $31.0 million in 2022, then slipped by 7.27% to $28.8 million in 2023, then plunged by 87.26% to $3.7 million in 2024, then surged by 1311.33% to $51.8 million in 2025, then soared by 35.36% to $70.1 million in 2026.
  • Business Quant data shows HYPD's Liabilities and Shareholders Equity at $70.1 million in Q1 2026, $51.8 million in Q4 2025, and $82.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Hyperion Defi 44.93 Mn 35.29 Mn 357,693.00 113.14 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 113.14 Mn
Mar 31, 2026 70.07 Mn
Dec 31, 2025 51.76 Mn
Sep 30, 2025 82.79 Mn
Jun 30, 2025 55.66 Mn
Mar 31, 2025 5.98 Mn
Dec 31, 2024 3.67 Mn
Sep 30, 2024 22.80 Mn
Jun 30, 2024 18.99 Mn
Mar 31, 2024 26.18 Mn
Dec 31, 2023 28.78 Mn
Sep 30, 2023 34.87 Mn
Jun 30, 2023 29.35 Mn
Mar 31, 2023 29.31 Mn
Dec 31, 2022 31.04 Mn
Sep 30, 2022 31.41 Mn
Jun 30, 2022 35.61 Mn
Mar 31, 2022 40.19 Mn
Dec 31, 2021 31.66 Mn
Sep 30, 2021 24.99 Mn